FDA Official to Recommend Pulling Avandia (causes of heart attack, etc)

[Guest guest]

FDA Official to Recommend Pulling Avandia-July 30, 2007 An official from the Food and Drug Administration (FDA) is set to meet with medical experts later today to recommend pulling the diabetes drug Avandia from the U.S. market. Avandia is often prescribed to patients with type-two diabetes and is manufactured by GlaxoSmithKline. Drug in Question FDA medical officer David Graham is meeting with medical experts to discuss the risks that have been associated with the drug. According to Graham, the drug increases cardiovascular risks while another drug, Actos, which has the same benefits for type-two diabetes and carry such risks. Type-two diabetes affects about 18 to 20 million Americans and is typically related with high blood glucose levels. GlaxoSmithKline is defending their product, which has been one of their top selling drugs. Agency Calls For a Meeting The agency is meeting with endocrinologic and metabolic drugs and drug safety and risk management committees to discuss the risks that are associated with the class of drugs that Avandia belongs to. The committee will then be asked to vote on the drug's future on the U.S. market One of the main questions to be discussed is whether Avandia carries risks that are greater than the other available medications and therapies. If voters find that Avandia should continue to be produced and sold, the committee will then have to decide whether the medication should only be given to certain patients and if a “black box” warning label should be put on the drug. (Source: Market Watch) Have you or someone you know been harmed by Avandia? Please contact us today to speak with a trustworthy attorney who will lead you in the right legal direction. http://www.adrugrecall.com/news/recommend-pulling-avandia.htmlPlavix Side Effects Fosamax Side Effects Paxil Birth Defect Trasylol Lawyer Viagra Blindness Ortho Evra Attorneys Consumer Drug Safety